AIFA published its 2025 Activity Report
The 2025 Activity Report of the Italian Medicines Agency (AIFA) is now available, providing an overview of the Agency’s evolution…
news
Update of C(nn) classification for medicinal products authorized through the centralized procedure
Today, the Italian Medicines Agency (AIFA) announced an update concerning the C(nn) classification for medicinal products authorized through the centralized…
OsMed Report 2025: how is pharmaceutical expenditure evolving in Italy?
AIFA has published the new OsMed Report 2025, which provides an updated overview of the use of medicinal products in…
Tavolo Tecnico di Coordinamento AIFA – Regioni: AIFA update
With Determination No. 41 of 28 July 2026, the Technical-Scientific Director of AIFA confirmed the “Tavolo Tecnico di Coordinamento AIFA…
New functionalities activated in the Registry of Observational Studies (RSO)
As of 4 December 2025, the new functionalities implemented in the Registry of Observational Studies (RSO) are active, with the…
AIFA 5% Fund: updated access criteria for orphan drugs and rare diseases
The Italian Medicines Agency (AIFA) has published an update on the access criteria for the AIFA 5% Fund, established by…
Report on AIFA Activities 2024
The Italian Medicines Agency (AIFA) has published the Report on Activities 2024, a document that recounts a particularly intense year,…
AIFA Independent Research Call 2025
The Italian Medicines Agency (AIFA) has published the second call for Independent Research, an initiative aimed at supporting pharmacological interventional…
New composition of the AIFA–Regions Working Table: national coordination on pharmaceutical policies strengthened
The Italian Medicines Agency (AIFA) has updated the composition of the AIFA–Regions Technical Coordination Table, established in January 2025 to…
AIFA reorganisation: HTA for equity of access and sustainability of the healthcare system
The Italian Medicines Agency (AIFA) announces the approval of the new Regulation on the functioning and organisation of personnel, a…